Exchange: NYSE
Industry: Health Care Equipment & Services
Last Trade: 4:01 PM ET 4/5/2013
Last 10 Quotes:
What's This?
| Fiscal Q4 Ending 12/12 |
Fiscal Q3 Ending 09/12 |
Fiscal Q2 Ending 06/12 |
Fiscal Q1 Ending 03/12 |
Fiscal Q4 Ending 12/11 |
|
Sales/Revenue |
437,563 | 381,120 | 374,802 | 322,979 | 324,145 |
Cost of Goods Sold (COGS) incl. D&A |
343,703 | 301,357 | 246,564 | 246,043 | 251,662 |
COGS excluding D&A |
301,098 | 268,896 | 213,571 | 213,473 | 219,355 |
Depreciation & Amortization Expense |
42,605 | 32,461 | 32,993 | 32,570 | 32,307 |
Gross Income |
93,860 | 79,763 | 128,238 | 76,936 | 72,483 |
SG&A Expense |
59,747 | 23,082 | 22,987 | 23,423 | 53,901 |
Research & Development |
0 | 0 | 0 | 0 | 0 |
Other SG&A |
59,747 | 23,082 | 22,987 | 23,423 | 53,901 |
Other Operating Expense |
0 | 30,960 | 82,049 | 31,171 | 0 |
Unusual Expense |
3,059 | 1,466 | 1,416 | 2,652 | -304 |
Non Operating Income/Expense |
176 | 743 | 361 | 520 | 662 |
Equity in Affiliates (Pretax) |
-76 | -28 | -80 | -392 | 0 |
Interest Expense |
60,862 | 38,451 | 38,587 | 39,045 | 41,418 |
Gross Interest Expense |
60,862 | 38,451 | 38,587 | 39,045 | 41,418 |
Pretax Income |
-29,603 | -13,380 | -16,422 | -19,123 | -21,870 |
Income Tax |
-2,078 | 324 | 324 | 272 | 362 |
Equity in Affiliates |
0 | 0 | 0 | 0 | -1,829 |
Consolidated Net Income |
-27,525 | -13,704 | -16,746 | -19,395 | -24,061 |
Minority Interest Expense |
-33 | -150 | -34 | -14 | -39 |
Net Income |
-27,492 | -13,554 | -16,712 | -19,381 | -24,022 |
Extraordinaries & Discontinued Operations |
0 | -2,698 | -5,007 | 0 | -3,915 |
Extra Items & Gain/Loss Sale Of Assets |
0 | 0 | 0 | 0 | -3,915 |
Cumulative Effect - Accounting Chg |
0 | 0 | 0 | 0 | 0 |
Discontinued Operations |
0 | -2,698 | -5,007 | NA | 0 |
Net Income After Extraordinaries |
-27,492 | -10,856 | -11,705 | -19,381 | -20,107 |
Preferred Dividends |
0 | 0 | 0 | 0 | 0 |
Net Income available to Common |
-27,492 | -13,554 | -16,712 | -19,381 | -24,022 |
Operational EPS |
-0.56 | -0.28 | -0.35 | -0.39 | -0.55 |
EPS (basic) |
-0.61 | -0.36 | -0.49 | -0.43 | -0.54 |
EBITDA |
76,718 | 58,182 | 56,195 | 54,912 | 50,889 |
Depreciation & Amortization Expense |
42,605 | 32,461 | 32,993 | 32,570 | 32,307 |
Common Shares Outstanding |
45,068 | 44,642 | 44,612 | 44,582 | 44,312 |
Basic Shares Outstanding |
45,068 | 44,642 | 44,612 | 44,582 | 44,312 |
Diluted Shares Outstanding |
45,068 | 44,642 | 44,612 | 44,582 | 44,312 |
Diluted EPS after Extraordinary Items |
-0.61 | -0.36 | -0.49 | -0.43 | -0.63 |
Discont. Operations Per Share |
0 | -0.06 | -0.11 | 0 | -0.09 |
Continued operations EPS |
-0.61 | -0.30 | -0.37 | -0.43 | -0.54 |
*Figures in thousands of U.S. Dollars except shares outstanding.
